Sequenced compared with simultaneous anthracycline and cyclophosphamide in high-risk stage I and II breast cancer: final analysis from INT-0137 (S9313). [electronic resource]
Producer: 20070327Description: 656-61 p. digitalISSN:- 1527-7755
- Adult
- Age Factors
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Breast Neoplasms -- drug therapy
- Cyclophosphamide -- administration & dosage
- Disease-Free Survival
- Dose-Response Relationship, Drug
- Doxorubicin -- administration & dosage
- Drug Administration Schedule
- Female
- Follow-Up Studies
- Humans
- Infusions, Intravenous
- Middle Aged
- Neoplasm Invasiveness -- pathology
- Neoplasm Staging
- Probability
- Risk Assessment
- Statistics, Nonparametric
- Survival Analysis
- Time Factors
No physical items for this record
Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.